Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.723384
Title: Exploring homework in second and third wave cognitive behavioural therapy
Author: Morgan, Louise
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2017
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Thesis embargoed until 05 May 2029
Access from Institution:
Abstract:
Volume one Volume one of the thesis comprises of three research chapters examining the use of therapeutic homework in second and third wave cognitive behavioural therapy. The first chapter is a correlational meta-analysis examining the relationship between mindfulness homework and improvement over a mindfulness course. The second chapter is an empirical study exploring the phenomenological experience of cognitive behavioural psychotherapists in using therapeutic homework. The final chapter is a public dissemination document providing an accessible summary of the meta-analysis and empirical paper. Volume two Volume two of the thesis consists of five clinical practice reports. The first report presents a cognitive behavioural and psychodynamic formulation of low self-esteem in an 18 year-old man. The second report evaluates the care package received by cluster eight clients in an adult mental health service. The third report describes a cognitive behavioural and systemic narrative intervention with a 72 year-old woman experiencing health anxiety. The fourth report presents a single-case experimental design to investigate the effectiveness of a behavioural intervention for challenging behaviour in a 32 year-old man with Rubinstein-Taybi Syndrome. The final report is an abstract of an oral presentation of clinical work completed in an early intervention service.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (D.Clin.Psy.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.723384  DOI: Not available
Keywords: BF Psychology ; RM Therapeutics. Pharmacology
Share: